Patricia holds her Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She also served as a PhD student research assistant in the Laboratory of Doctor David A. Fidock, Department of Microbiology & Immunology, Columbia University, New York.
Daily treatment with setmelanotide for one year significantly reduced body weight and hunger in Bardet-Biedl syndrome (BBS) patients with severe obesity, a Phase 2/3 trial shows. The study, “Effect of ... Read more
A broad diagnostic approach that takes into account genetics, hormonal changes, cognitive impairments, and medication use may help identify the underlying cause of pediatric obesity in almost 20% of ... Read more
A new case report described the rare case of a girl with Bardet-Biedl syndrome (BBS) who experienced hearing loss and bronchopneumonia. The research, “A Unique Manifestation of Bardet-Biedl Syndrome ... Read more
Rhythm Pharmaceuticals is planning to expand its ongoing Phase 2 basket study investigating setmelanotide as an obesity treatment. The enlarged trial will include four additional genetic obesity disorders caused ... Read more
Pin It on Pinterest